The treatment of cardiovascular diseases and obesity, two diseases posing a major risk to
human health, has been plagued by the scarcity of potent and effective medication with …

Acute coronary syndrome (ACS) remains a major cause of morbidity and mortality
worldwide, requiring ongoing efforts to identify novel therapeutic targets to improve patient …

Etiology of hepatic steatosis and metabolic dysfunction-associated fatty liver disease
(MAFLD) among acute coronary syndrome (ACS) remains unclear. Existing studies …

In individuals with very low high-density lipoprotein (HDL-C) cholesterol, such as Tangier
disease, LCAT deficiency, and familial hypoalphalipoproteinemia, there is an increased risk …

Abstract Background As a traditional Chinese medicinal herb, the lipid-lowing biological
potential of Eucommia ulmoides leaves (EL) has been demonstrated. After fermentation, the …

Atherosclerosis is a significant risk factor for coronary heart disease (CHD) and myocardial
infarction (MI). Atherosclerosis develops during foam cell generation, which is caused by an …

Cardiovascular diseases (CVDs), encompassing coronary artery disease, heart failure,
stroke, and hypertension, are a significant public health concern. Nearly half (48.6%) of …

Diabetic kidney disease (DKD) is a devastating kidney disease and lacks effective
therapeutic interventions. The present study was aimed to determine whether reconstituted …

Mostly, cardiovascular diseases are blamed for casualties in rheumatoid arthritis (RA)
patients. Customarily, dyslipidemia is probably the most prevalent underlying cause of …

Can apoA-I infusion decrease cardiovascular events? Page 1 European Heart Journal (2024)
00, 1–3 https://doi.org/10.1093/eurheartj/ehae774 EDITORIAL Ischaemic heart disease Can …